Anxiety / depression visit
SSRI/SNRI management
About Anxiety / depression visit
An anxiety and depression visit screens with validated tools (PHQ-9, GAD-7) and reviews onset, severity, functional impact, sleep, substance use, prior treatments, and suicide risk. Differential includes hypothyroidism, perimenopause, anemia, vitamin deficiencies, sleep apnea, and medication effects. First-line treatments are cognitive behavioral therapy plus an SSRI or SNRI; response is typically assessed at 4–8 weeks with dose titration, and partial responders may benefit from switching or augmentation. Patients with bipolar features, psychosis, or substance use disorders should be evaluated before starting antidepressants alone.